Transglutaminase 2 and NF-κB: an odd couple that shapes breast cancer phenotype

NF- B, the first quarter-century: remarkable progress and outstanding questions

(2012) M. S. Hayden et al.   GENES & DEVELOPMENT

Ataxia-Telangiectasia, Mutated (ATM)/Nuclear Factor κ Light Chain Enhancer of Activated B Cells (NFκB) Signaling Controls Basal and DNA Damage-induced Transglutaminase 2 Expression

(2012) Lingbao Ai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Integration of Genetic and Immunological Insights into a Model of Celiac Disease Pathogenesis

(2011) Valérie Abadie et al.   Annual Review of Immunology

Prostate transglutaminase: a unique transglutaminase and its role in prostate cancer

(2011) Wen G Jiang et al.   Biomarkers in Medicine

LUBAC regulates NF-κB activation upon genotoxic stress by promoting linear ubiquitination of NEMO

(2011) Jixiao Niu et al.   EMBO JOURNAL

Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+-dependent action of a multifunctional protein

(2011) Róbert Király et al.   FEBS Journal

Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells

(2011) Anupam Kumar et al.   PLoS One

I-κBα depletion by transglutaminase 2 and μ-calpain occurs in parallel with the ubiquitin–proteasome pathway

(2010) Dae-Seok Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The transglutaminase 2 gene is aberrantly hypermethylated in glioma

(2010) Lisa M. Dyer et al.   JOURNAL OF NEURO-ONCOLOGY

ATM- and NEMO-Dependent ELKS Ubiquitination Coordinates TAK1-Mediated IKK Activation in Response to Genotoxic Stress

(2010) Zhao-Hui Wu et al.   MOLECULAR CELL

Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells

(2010) Anupam Kumar et al.   PLoS One

ATM Activation by Oxidative Stress

(2010) Z. Guo et al.   SCIENCE

Protein 4.2 : A complex linker

(2009) Timothy J. Satchwell et al.   BLOOD CELLS MOLECULES AND DISEASES

Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase

(2009) M. Shao et al.   CANCER RESEARCH

Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection

(2009) Linda Connelly et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Transglutaminase 2 Deficiency Decreases Plaque Fibrosis and Increases Plaque Inflammation in Apolipoprotein-E-Deficient Mice

(2009) Jozef L. Van Herck et al.   JOURNAL OF VASCULAR RESEARCH

Transglutaminase inhibition ameliorates experimental diabetic nephropathy

(2009) Linghong Huang et al.   KIDNEY INTERNATIONAL

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling

(2008) L. Cao et al.   CARCINOGENESIS

The transglutaminase 2 gene ( TGM2 ), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer

(2008) Lingbao Ai et al.   CARCINOGENESIS

Therapeutic Significance of Elevated Tissue Transglutaminase Expression in Pancreatic Cancer

(2008) A. Verma et al.   CLINICAL CANCER RESEARCH

The role of the DNA damage response in neuronal development, organization and maintenance

(2008) Ari Barzilai et al.   DNA REPAIR

NF-κB and epithelial to mesenchymal transition of cancer

(2008) Chengyin Min et al.   JOURNAL OF CELLULAR BIOCHEMISTRY